Direkt zum Inhalt
Merck
  • [Use of nicotinic acid and midocalm for correcting blood coagulation in patients with radiation edema of the extremities].

[Use of nicotinic acid and midocalm for correcting blood coagulation in patients with radiation edema of the extremities].

Meditsinskaia radiologiia (1985-08-01)
S I Chekalina, L I Guseva, M S Bardyechev
ZUSAMMENFASSUNG

A study was made of the functional activity of platelets, plasmatic coagulation and fibrinolysis in patients with late radiation disorders of the blood and lymph flow during treatment with vasodilative drugs: nicotinic acid and midocalm. These drugs tend to decrease the functional activity of platelets and to raise the blood fibrinolytic activity. Their use is indicated to this group of patients to better their intravascular status.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Nicotinsäure, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinsäure, ≥98%
Supelco
Nicotinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Nicotinsäure, analytical standard
Sigma-Aldrich
Nicotinsäure, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Nicotinsäure, meets USP testing specifications